DOCSLIB.ORG

Drug Enforcement Administration, Justice § 1308.13

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Drug Enforcement Administration, Justice § 1308.13 (2) Methamphetamine, its salts, (ii) 1- isomers, and salts of its iso- piperidinocyclohexanecarboni- mers ........................................ 1105 trile (PCC) ............................... 8603 (3) Phenmetrazine and its salts 1631 (3) Immediate precursor to fentanyl: (4) Methylphenidate ................... 1724 (5) Lisdexamfetamine, its salts, (i) 4-anilino-N-phenethyl-4-pi- isomers, and salts of its iso- peridine (ANPP) ...................... 8333 mers ........................................ 1205. (ii) [Reserved] (e) Depressants. Unless specifically [39 FR 22142, June 20, 1974] excepted or unless listed in another EDITORIAL NOTE: For FEDERAL REGISTER ci- schedule, any material, compound, tations affecting § 1308.12, see the List of CFR mixture, or preparation which contains Sections Affected, which appears in the any quantity of the following sub- Finding Aids section of the printed volume stances having a depressant effect on and at www.fdsys.gov. the central nervous system, including its salts, isomers, and salts of isomers § 1308.13 Schedule III. whenever the existence of such salts, (a) Schedule III shall consist of the isomers, and salts of isomers is possible drugs and other substances, by what- within the specific chemical designa- ever official name, common or usual tion: name, chemical name, or brand name (1) Amobarbital .......................... 2125 designated, listed in this section. Each (2) Glutethimide ......................... 2550 drug or substance has been assigned (3) Pentobarbital ........................ 2270 the DEA Controlled Substances Code (4) Phencyclidine ....................... 7471 Number set forth opposite it. (5) Secobarbital .......................... 2315 (b) Stimulants. Unless specifically ex- cepted or unless listed in another (f) Hallucinogenic substances. schedule, any material, compound, (1) Nabilone .............................. 7379 mixture, or preparation which contains [Another name for any quantity of the following sub- nabilone: (±)-trans-3-(1,1- stances having a stimulant effect on dimethylheptyl)- the central nervous system, including 6,6a,7,8,10,10a-hexahydro- its salts, isomers (whether optical, po- 1-hydroxy-6,6-dimethyl- sitional, or geometric), and salts of 9H-dibenzo[b,d]pyran-9- such isomers whenever the existence of one] such salts, isomers, and salts of iso- (2) Dronabinol [(-)-delta-9-trans mers is possible within the specific tetrahydrocannabinol] in an chemical designation: oral solution in a drug prod- (1) Those compounds, mixtures, uct approved for marketing or preparations in dosage unit by the U.S. Food and Drug form containing any stimu- Administration ...................... (7365) lant substances listed in (g) Immediate precursors. Unless spe- schedule II which compounds, cifically excepted or unless listed in mixtures, or preparations were another schedule, any material, com- listed on August 25, 1971, as ex- pound, mixture, or preparation which cepted compounds under contains any quantity of the following § 1308.32, and any other drug of substances: the quantitative composition (1) Immediate precursor to amphet- shown in that list for those amine and methamphetamine: drugs or which is the same ex- cept that it contains a lesser (i) Phenylacetone ....................... 8501 quantity of controlled sub- Some trade or other names: stances .................................... 1405 phenyl-2-propanone; P2P; (2) Benzphetamine ...................... 1228 benzyl methyl ketone; (3) Chlorphentermine ................. 1645 methyl benzyl ketone; (4) Clortermine ........................... 1647 (2) Immediate precursors to (5) Phendimetrazine ................... 1615 phencyclidine (PCP): (c) Depressants. Unless specifically (i) 1-phenylcyclohexylamine ...... 7460 excepted or unless listed in another 119 VerDate Sep<11>2014 11:54 May 19, 2017 Jkt 241078 PO 00000 Frm 00129 Fmt 8010 Sfmt 8010 Y:\SGML\241078.XXX 241078 rmajette on DSKBCKNHB2PROD with CFR § 1308.13 21 CFR Ch. II (4–1–17 Edition) schedule, any material, compound, Some trade or other names mixture, or preparation which contains for a tiletamine-zolazepam any quantity of the following sub- combination product: stances having a depressant effect on Telazol.. the central nervous system: Some trade or other names (1) Any compound, mixture or for tiletamine: preparation containing: 2-(ethylamino)-2-(2- (i) Amobarbital .............. 2126 thienyl)- (ii) Secobarbital ............. 2316 cyclohexanone.. (iii) Pentobarbital .......... 2271 Some trade or other names or any salt thereof and one for zolazepam: or more other active me- 4-(2-fluorophenyl)-6,8- dicinal ingredients which dihydro-1,3,8- are not listed in any trimethylpyrazolo-[3,4- schedule. e] [1,4]-diazepin-7(1H)- (2) Any suppository dosage form one, flupyrazapon.. containing: (d) Nalorphine 9400. (i) Amobarbital .............. 2126 (e) Narcotic drugs. Unless specifically (ii) Secobarbital ............. 2316 excepted or unless listed in another (iii) Pentobarbital .......... 2271 schedule: or any salt of any of these (1) Any material, compound, drugs and approved by the mixture, or preparation con- Food and Drug Adminis- taining any of the following tration for marketing only narcotic drugs, or their salts as a suppository. calculated as the free anhy- (3) Any substance which con- drous base or alkaloid, in lim- tains any quantity of a deriva- ited quantities as set forth tive of barbituric acid or any below: salt thereof ............................. 2100 (i) Not more than 1.8 (4) Chlorhexadol ......................... 2510 grams of codeine per (5) Embutramide ........................ 2020 100 milliliters or not (6) Any drug product containing more than 90 milli- gamma hydroxybutyric acid, grams per dosage unit, including its salts, isomers, with an equal or great- and salts of isomers, for which er quantity of an an application is approved isoquinoline alkaloid under section 505 of the Fed- of opium ...................... 9803 eral Food, Drug, and Cosmetic (ii) Not more than 1.8 Act .......................................... 2012 grams of codeine per (7) Ketamine, its salts, isomers, 100 milliliters or not and salts of isomers ................ 7285 more than 90 milli- [Some other names for grams per dosage unit, ketamine: (±)-2-(2- with one or more ac- chlorophenyl)-2- tive, nonnarcotic in- (methylamino)- gredients in recognized cyclohexanone] therapeutic amounts ... 9804 (8) Lysergic acid ......................... 7300 (iii) Not more than 1.8 (9) Lysergic acid amide .............. 7310 grams of (10) Methyprylon ........................ 2575 dihydrocodeine per 100 (11) Perampanel, and its salts, milliliters or not more isomers, and salts of isomers .. 2261 than 90 milligrams per (12) Sulfondiethylmethane ......... 2600 dosage unit, with one (13) Sulfonethylmethane ............ 2605 or more active nonnar- cotic ingredients in (14) Sulfonmethane .................... 2610 recognized therapeutic (15) Tiletamine and zolazepam amounts ...................... 9807 or any salt thereof .................. 7295 120 VerDate Sep<11>2014 11:54 May 19, 2017 Jkt 241078 PO 00000 Frm 00130 Fmt 8010 Sfmt 8010 Y:\SGML\241078.XXX 241078 rmajette on DSKBCKNHB2PROD with CFR Drug Enforcement Administration, Justice § 1308.14 (iv) Not more than 300 EDITORIAL NOTE: For FEDERAL REGISTER ci- milligrams of tations affecting § 1308.13, see the List of CFR Sections Affected, which appears in the ethylmorphine per 100 Finding Aids section of the printed volume milliliters or not more and at www.fdsys.gov. than 15 milligrams per dosage unit, with one § 1308.14 Schedule IV. or more active, non- (a) Schedule IV shall consist of the narcotic ingredients in drugs and other substances, by what- recognized therapeutic ever official name, common or usual amounts ...................... 9808 name, chemical name, or brand name (v) Not more than 500 designated, listed in this section. Each milligrams of opium drug or substance has been assigned per 100 milliliters or the DEA Controlled Substances Code per 100 grams or not Number set forth opposite it. more than 25 milli- (b) Narcotic drugs. Unless specifically grams per dosage unit, excepted or unless listed in another with one or more ac- schedule, any material, compound, tive, nonnarcotic in- mixture, or preparation containing any gredients in recognized of the following narcotic drugs, or therapeutic amounts ... 9809 their salts calculated as the free anhy- (vi) Not more than 50 drous base or alkaloid, in limited quan- milligrams of mor- tities as set forth below: phine per 100 milli- (1) Not more than 1 milligram of liters or per 100 grams, difenoxin and not less than 25 with one or more ac- micrograms of atropine sul- tive, nonnarcotic in- fate per dosage unit ................ 9167 gredients in recognized (2) Dextropropoxyphene (alpha- therapeutic amounts ... 9810 (+)-4-dimethylamino-1,2-di- (2) Any material, compound, phenyl-3-methyl-2- mixture, or preparation con- propionoxybutane) .................. 9278 taining any of the following (3) 2-[(dimethylamino)methyl]-1- narcotic drugs or their salts, (3- as set forth below: methoxyphenyl)cyclohexanol, (i) Buprenorphine ........... 9064 its salts, optical and geo- (ii) [Reserved]. metric isomers and salts of these isomers (including (f) Anabolic Steroids. Unless specifi- tramadol) ................................ 9752 cally excepted or unless listed in an- other schedule, any material, com- (c) Depressants. Unless specifically pound, mixture
Recommended publications
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

    Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1

    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
  • Telazol® CIII(Tiletamine and Zolazepam for Injection)

    Telazol® CIII(Tiletamine and Zolazepam for Injection)

    TELAZOL- tiletamine hydrochloride and zolazepam hydrochloride injection, powder, for solution Zoetis Inc. ---------- Telazol® CIII (tiletamine and zolazepam for injection) 100 mg/mL total (equivalent to 50 mg/mL tiletamine and 50 mg/mL zolazepam) For Intramuscular and Intravenous injection in Dogs For Intramuscular injection only in Cats CAUTION Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION TELAZOL (tiletamine and zolazepam for injection) is a nonnarcotic, nonbarbiturate, injectable anesthetic agent for dogs and cats. Chemically, TELAZOL is a combination of equal parts by weight of base of tiletamine hydrochloride (2-[ethylamino]-2-[2-thienyl]-cyclohexanone hydrochloride), an arylaminocycloalkanone dissociative anesthetic, and zolazepam hydrochloride (4-[o-fluorophenyl]-6, 8-dihydro-1,3,8- trimethylpyrazolo [3, 4-e][1,4] diazepin-7 [1H]-1- hydrochloride), a nonphenothiazine diazepinone having minor tranquilizing properties. The product is supplied sterile in vials. The addition of 5 mL diluent produces a solution containing the equivalent of 50 mg tiletamine base, 50 mg zolazepam base and 57.7 mg mannitol per milliliter. This solution has a pH of 2 to 3.5 and is recommended for deep intramuscular injection. INDICATIONS Dogs TELAZOL is indicated in dogs for restraint and minor procedures of short duration (30 min. avg.) requiring mild to moderate analgesia. Minor surgery is considered to be laceration repair, draining of abscesses, castrations and other procedures requiring mild to moderate analgesia. (See Dogs under Dosage and Administration.) TELAZOL administered intravenously is indicated in dogs for induction of anesthesia followed by maintenance with an inhalant anesthetic. Cats TELAZOL is indicated in cats for restraint or for anesthesia combined with muscle relaxation.
  • Pharmacological Treatments in Insomnia

    Pharmacological Treatments in Insomnia

    Pharmacological treatments in insomnia Sue Wilson Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College, London Drugs used in insomnia Licensed for insomnia •GABA-A positive allosteric modulators •melatonin (modified release) •promethazine •diphenhydramine •doxepin (USA) Unlicensed prescribed frequently •antihistamines (and OTC) •antidepressants Sometimes prescribed drugs for psychosis Some GABA-A positive allosteric modulators Drugs acting at the GABA-A benzodiazepine receptor zopiclone zolpidem zaleplon benzodiazepines eg temazepam, lorazepam (safe in overdose, as long as no other drug involved) Drugs acting at the barbiturate/alcohol receptor chloral hydrate/chloral betaine clomethiazole (dangerous in overdose) GABA calms the brain Gamma aminobutyic acid (GABA) is the main inhibitory transmitter in the mammalian central nervous system. It plays the principal role in reducing neuronal excitability and its receptors are prolific throughout the brain, in cortex, limbic system, thalamus and cerebellum sedative Increase anticonvulsant GABA anxiolytic function ataxia, memory effects Effects of GABA-A positive allosteric modulators •These drugs enhance the effect of GABA, the main inhibitory neurotransmitter in the brain •They all produce sedation, sleep promotion, ataxia, muscle relaxation, effects on memory, anticonvulsant effects •Therefore for insomnia the duration of action of the drug is important – these effects are unwanted during the day Effects of these GABA-ergic drugs on sleep EEG/PSG • Appearance of
  • 124.210 Schedule IV — Substances Included. 1

    124.210 Schedule IV — Substances Included. 1

    1 CONTROLLED SUBSTANCES, §124.210 124.210 Schedule IV — substances included. 1. Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. 2. Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: a. Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit. b. Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane). c. 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol). 3. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: a. Alprazolam. b. Barbital. c. Bromazepam. d. Camazepam. e. Carisoprodol. f. Chloral betaine. g. Chloral hydrate. h. Chlordiazepoxide. i. Clobazam. j. Clonazepam. k. Clorazepate. l. Clotiazepam. m. Cloxazolam. n. Delorazepam. o. Diazepam. p. Dichloralphenazone. q. Estazolam. r. Ethchlorvynol. s. Ethinamate. t. Ethyl Loflazepate. u. Fludiazepam. v. Flunitrazepam. w. Flurazepam. x. Halazepam. y. Haloxazolam. z. Ketazolam. aa. Loprazolam. ab. Lorazepam. ac. Lormetazepam. ad. Mebutamate. ae. Medazepam. af. Meprobamate. ag. Methohexital. ah. Methylphenobarbital (mephobarbital).
  • Veterinary Anesthetic and Analgesic Formulary 3Rd Edition, Version G

    Veterinary Anesthetic and Analgesic Formulary 3Rd Edition, Version G

    Veterinary Anesthetic and Analgesic Formulary 3rd Edition, Version G I. Introduction and Use of the UC‐Denver Veterinary Formulary II. Anesthetic and Analgesic Considerations III. Species Specific Veterinary Formulary 1. Mouse 2. Rat 3. Neonatal Rodent 4. Guinea Pig 5. Chinchilla 6. Gerbil 7. Rabbit 8. Dog 9. Pig 10. Sheep 11. Non‐Pharmaceutical Grade Anesthetics IV. References I. Introduction and Use of the UC‐Denver Formulary Basic Definitions: Anesthesia: central nervous system depression that provides amnesia, unconsciousness and immobility in response to a painful stimulation. Drugs that produce anesthesia may or may not provide analgesia (1, 2). Analgesia: The absence of pain in response to stimulation that would normally be painful. An analgesic drug can provide analgesia by acting at the level of the central nervous system or at the site of inflammation to diminish or block pain signals (1, 2). Sedation: A state of mental calmness, decreased response to environmental stimuli, and muscle relaxation. This state is characterized by suppression of spontaneous movement with maintenance of spinal reflexes (1). Animal anesthesia and analgesia are crucial components of an animal use protocol. This document is provided to aid in the design of an anesthetic and analgesic plan to prevent animal pain whenever possible. However, this document should not be perceived to replace consultation with the university’s veterinary staff. As required by law, the veterinary staff should be consulted to assist in the planning of procedures where anesthetics and analgesics will be used to avoid or minimize discomfort, distress and pain in animals (3, 4). Prior to administration, all use of anesthetics and analgesic are to be approved by the Institutional Animal Care and Use Committee (IACUC).
  • Introduced B.,Byhansen, 16

    Introduced B.,Byhansen, 16

    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
  • Outline for Controlled Substances Program

    Outline for Controlled Substances Program

    Environmental Health and Safety Controlled Substances Program Date of Issuance: Review Date: 10/1/2019 (no changes) 10/01/2018 Revision Number: Initial Prepared by: EH&S Table of Contents HEADINGS Introduction Applicability Responsibilities Registration Requirements Authorized Use Ordering/Purchasing Administering and Dispensing Inventory Procedures (Continuing Records) Security Disposal FORMS: Registering or renewing a DEA or state license (CMU) Controlled Substances Authorized users list (CMU) Employee questionnaire for those with access to controlled substances (CMU) Record of Form 222 use (Order form) (CMU) Records of Controlled Substance Purchases (CMU) Record of Controlled Substance Administering and dispensing (CMU) Controlled Substance Physical Inventory (CMU) DEA Registration of Persons doing research or analysis (Form 225) DEA Registration of Dispensers (Form 224) DEA Registration Instructional (Form 224 and 226 to renew) DEA Report of loss or theft (Form 106) DEA Report of drugs surrendered (From 41) DEA SCHEDULES: Schedule I Schedule II Schedule III Schedule IV Schedule V INTRODUCTION State and Federal regulations have been promulgated concerning the use and handling of US Department of Justice Drug Enforcement Administration (DEA) controlled substances. These regulations are in place to address materials which are or have the potential to be addictive or habit forming. These substances have been categorized into “schedules” that have been created by the DEA to reflect their level of concern. The “Carnegie Mellon University DEA Controlled Substances Program” is intended to ensure that Carnegie Mellon University is in compliance with our regulatory requirements. Required activities under the DEA include: 1. Registration of your work with the DEA and with Carnegie Mellon’s Department of Environmental Health and Safety (EH&S).
  • Drug and Medication Classification Schedule

    Drug and Medication Classification Schedule

    KENTUCKY HORSE RACING COMMISSION UNIFORM DRUG, MEDICATION, AND SUBSTANCE CLASSIFICATION SCHEDULE KHRC 8-020-1 (11/2018) Class A drugs, medications, and substances are those (1) that have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration, or (2) that lack approval by the United States Food and Drug Administration but have pharmacologic effects similar to certain Class B drugs, medications, or substances that are approved by the United States Food and Drug Administration. Acecarbromal Bolasterone Cimaterol Divalproex Fluanisone Acetophenazine Boldione Citalopram Dixyrazine Fludiazepam Adinazolam Brimondine Cllibucaine Donepezil Flunitrazepam Alcuronium Bromazepam Clobazam Dopamine Fluopromazine Alfentanil Bromfenac Clocapramine Doxacurium Fluoresone Almotriptan Bromisovalum Clomethiazole Doxapram Fluoxetine Alphaprodine Bromocriptine Clomipramine Doxazosin Flupenthixol Alpidem Bromperidol Clonazepam Doxefazepam Flupirtine Alprazolam Brotizolam Clorazepate Doxepin Flurazepam Alprenolol Bufexamac Clormecaine Droperidol Fluspirilene Althesin Bupivacaine Clostebol Duloxetine Flutoprazepam Aminorex Buprenorphine Clothiapine Eletriptan Fluvoxamine Amisulpride Buspirone Clotiazepam Enalapril Formebolone Amitriptyline Bupropion Cloxazolam Enciprazine Fosinopril Amobarbital Butabartital Clozapine Endorphins Furzabol Amoxapine Butacaine Cobratoxin Enkephalins Galantamine Amperozide Butalbital Cocaine Ephedrine Gallamine Amphetamine Butanilicaine Codeine
  • 2015R3015 1 Senate Bill No. 458 2

    2015R3015 1 Senate Bill No. 458 2

    2015R3015 1 Senate Bill No. 458 2 (By Senators Stollings and Kessler) 3 ____________ 4 [Introduced February 11, 2015; referred to the Committee on Health and Human Resources; and 5 then to the Committee on the Judiciary.] 6 ____________ 7 8 9 10 A BILL to amend and reenact §60A-2-210 and §60A-2-212 of the Code of West Virginia, 1931, as 11 amended; and to amend and reenact §60A-10-2, §60A-10-4 and §60A-10-7 of said code, all 12 relating to controlling methamphetamine; requiring prescription to dispense drug products 13 that contain active ingredient ephedrine, pseudoephedrine, phenylpropanolamine and other 14 precursors of methamphetamine; moving certain drug products from Schedule V to Schedule 15 IV; providing exception for drug products that cannot be feasibly converted into 16 methamphetamine; defining terms; prohibiting pharmacies from selling certain drugs that can 17 be used in production of methamphetamine without a prescription; creating criminal offense 18 for possession of certain substances without a prescription with intent to transfer to another 19 to make methamphetamine; removing outdated language; providing criminal penalties; and 20 providing rule-making authority. 21 Be it enacted by the Legislature of West Virginia: 1 2015R3015 1 That §60A-2-210 and §60A-2-212 of the Code of West Virginia, 1931, as amended, be 2 amended and reenacted; and that §60A-10-2, §60A-10-4 and §60A-10-7 of said code be amended 3 and reenacted, all to read as follows: 4 ARTICLE 2. STANDARDS AND SCHEDULES. 5 §60A-2-210. Schedule IV.
  • Tennessee Drug Statutes (Listed in Numerical Order)

    Tennessee Drug Statutes (Listed in Numerical Order)

    Tennessee Drug Statutes (listed in numerical order) 39-17-405. Criteria for Schedule I. • The commissioner of mental health and substance abuse services, upon the agreement of the commissioner of health, shall place a substance in Schedule I upon finding that the substance has: o (1) High potential for abuse; and o (2) No accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision. 39-17-406. Controlled substances in Schedule I. • (a) Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. • (b) Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation. For the purposes of subdivision (b)(34) only, the term isomer includes the optical and geometric isomers. o (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- piperidinyl]-N-phenylacetamide); o (2) Acetylmethadol; o (3) Allylprodine; o (4) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM); o (5) Alphameprodine; o (6) Alphamethadol; o (7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4- piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido)piperidine;
  • Tiletamine-Zolazepam Anesthesia in North American River Otters (Lutra Canadensis) and Its Partial Antagonism with Flumazenil

    Tiletamine-Zolazepam Anesthesia in North American River Otters (Lutra Canadensis) and Its Partial Antagonism with Flumazenil

    ]OUf7/U[ (~rZOO and Wild/~re M(>dicine 28(4): 418-423,1997 Copyright 1997 by American Association of Zoo Veterinarians TILETAMINE-ZOLAZEPAM ANESTHESIA IN NORTH AMERICAN RIVER OTTERS (LUTRA CANADENSIS) AND ITS PARTIAL ANTAGONISM WITH FLUMAZENIL Lucy H. Spelman, D.V.M., Perry W. Sumner, M.S., William B. Karesh, D.V.M., and Michael K. Stoskopf, D.V.M., Ph.D. Abstract: North American river otters (Lutra canadensis) were anesthetized with tiletamine-zolazepam or tiletamine­ zolazepam-flumazenil combinations in cooperation with the North Carolina Wildlife Resources Commission Otter Restoration Project for evaluation of physiologic changes during anesthesia. Sixteen otters received tiletamine-zolaze­ pam (4 mg/kg combined, i.m.) in 1994. Induction and recovery times were recorded and physiologic data (heart rate and rhythm, respiratory rate, rectal temperature, relative oxyhemoglobin saturation, and mean arterial blood pressure) were collected at 5-min intervals. Respiratory depression developed initially in all otters, and median relative oxyhe­ moglobin saturation remained below 90% for the first 15 min of anesthesia. Anesthetic induction with tiletamine­ zolazepam was rapid and smooth, but recovery was prolonged (median = 89 min) and characterized by persistent head motion. In 1995, flumazenil was evaluated as a partial antagonist for tiletamine-zolazepam anesthesia in otters. Sixteen otters were anesthetized with tiletamine-zolazepam (4 mg/kg combined, i.m.) and given flumazenil (I mg per 25 mg of zolazepam) after 20 min. Flumazenil markedly shortened recovery time in all otters anesthetized with tiletamine­ zolazepam (median = 65 min) with no adverse effects. Key words: River otter, Lutra canadensis, anesthesia, tiletamine-zolazepam, flumazenil. INTRODUCTION ratory depression produced by diazepam and mid­ 7 9 azolam.4.
  • Laws 2021, LB236, § 4

    Laws 2021, LB236, § 4

    LB236 LB236 2021 2021 LEGISLATIVE BILL 236 Approved by the Governor May 26, 2021 Introduced by Brewer, 43; Clements, 2; Erdman, 47; Slama, 1; Lindstrom, 18; Murman, 38; Halloran, 33; Hansen, B., 16; McDonnell, 5; Briese, 41; Lowe, 37; Groene, 42; Sanders, 45; Bostelman, 23; Albrecht, 17; Dorn, 30; Linehan, 39; Friesen, 34; Aguilar, 35; Gragert, 40; Kolterman, 24; Williams, 36; Brandt, 32. A BILL FOR AN ACT relating to law; to amend sections 28-1202 and 69-2436, Reissue Revised Statutes of Nebraska, and sections 28-401 and 28-405, Revised Statutes Cumulative Supplement, 2020; to redefine terms, change drug schedules, and adopt federal drug provisions under the Uniform Controlled Substances Act; to provide an exception to the offense of carrying a concealed weapon as prescribed; to define a term; to change provisions relating to renewal of a permit to carry a concealed handgun; to provide a duty for the Nebraska State Patrol; to eliminate an obsolete provision; to harmonize provisions; and to repeal the original sections. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2020, is amended to read: 28-401 As used in the Uniform Controlled Substances Act, unless the context otherwise requires: (1) Administer means to directly apply a controlled substance by injection, inhalation, ingestion, or any other means to the body of a patient or research subject; (2) Agent means an authorized person who acts on behalf of or at the direction of another person but does not include a common or contract carrier, public warehouse keeper, or employee of a carrier or warehouse keeper; (3) Administration means the Drug Enforcement Administration of the United States Department of Justice; (4) Controlled substance means a drug, biological, substance, or immediate precursor in Schedules I through V of section 28-405.